Real-World Evidence Insights - 12.12.24

Technical Innovation

Generative AI: Revolutionising Clinical Trials for Faster Therapeutic Innovations

This week the World Economic Forum release their white paper on how generative AI can transform clinical trials, reducing the 12-year timeline and $2.5 billion cost of drug development. By improving trial design and data management, Gen AI addresses inefficiencies, potentially saving lives. Collaboration among stakeholders is crucial to harness AI potential and deliver treatments faster and more effectively.

Clinical Data Innovation: Transforming Trials with Compassionate Collaboration and Science

Clinical data innovation is prioritising risk-based quality management over unchecked AI adoption, focusing on harmonised data and collaboration with research sites. The shift towards data science requires new skills and tools, aiming for standardisation and automation. Continuous improvement and collaboration promise enhanced trial efficiency and patient care.

Harnessing Data Analytics to Revolutionise Clinical Trials for Better Outcomes

Data analytics and AI are transforming clinical trials by enabling real-time data access, improving efficiency, and enhancing decision-making. While AI offers predictive insights, human expertise remains crucial. Balancing technology with operational efficiency is key for CROs, especially in specialised fields like dermatology and rheumatology.

Transforming Patient Registries: Embracing Technology for Enhanced Healthcare Insights

Patient registries are evolving with technology, enhancing real world evidence (RWE) collection. New digital tools reduce data collection burdens, enabling more comprehensive and diverse data. This transformation supports better patient care and drug development, offering hope for improved healthcare outcomes through more accessible and efficient research methods.

Regulation Spotlight

Streamlined Compliance Software: Transforming Pharmaceutical Launches and Regulatory Processes

The Medical, Legal, and Regulatory (MLR) Review Software market is set to grow significantly, driven by regulatory complexities and the need for faster product launches. Technological advancements like AI and cloud solutions enhance compliance processes, making MLR software crucial for efficient, transparent, and collaborative operations in healthcare.

In the News

Ontada Unveils Transformative Oncology Solutions and Research at ASH 2024 Event

Ontada, a McKesson business, is showcasing real-world research and launching new solutions at ASH 2024. Their studies focus on improving cancer care through data-driven insights. New tools, ON.Sight and ON.Path, aim to enhance oncology practices, supporting patients and providers with vital information for better treatment outcomes.